Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
2002 · Blood · 400 citations
https://doi.org/10.1182/blood.v99.12.4364
J
Joost W. J. van Esser
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
2.1K
Citations
17
h-index
19
i10-index
Joost W. J. van Esser is an academic researcher from Amphia Ziekenhuis. The author has contributed to research in topics: Cytomegalovirus and herpesvirus research & Viral-associated cancers and disorders & Parvovirus B19 Infection Studies. The author has an h-index of 17, co-authored 32 publications.
Papers by this author
worksRapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia
2008 · Leukemia · 83 citations
https://doi.org/10.1038/leu.2008.318
Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands
2019 · Medical Mycology Case Reports · 22 citations
https://doi.org/10.1016/j.mmcr.2019.01.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat